Abstract

Transitional cell carcinoma (TCC) is the most common tumour of the canine urinary bladder. It is highly locally invasive and carries a moderate to high risk of metastasis. Clinical signs are typically attributed to the primary disease, and may mimic those of a lower urinary tract infection. The gold standard for definitive diagnosis is histopathology of tissue obtained by traumatic catheterisation, cystoscopy or surgery. Staging includes thoracic and abdominal imaging to aid in the determination of prognosis. Due to the limitations of local treatment for TCC, medical treatment with systemic chemotherapy and non-steroidal anti-inflammatories remains the mainstay of therapy. Surgery is rarely feasible as the most common location for TCC is the trigone. With the rapid development of interventional radiology in veterinary medicine during the last decade, urethral stents have become a non-invasive and effective approach for relieving partial or complete malignant urinary obstructions, which are common in dogs with advanced TCC.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.